Filing Details
- Accession Number:
- 0000315066-14-001657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-05 18:59:13
- Reporting Period:
- 2014-01-30
- Filing Date:
- 2014-02-05
- Accepted Time:
- 2014-02-05 18:59:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-01-30 | 2,912,443 | $0.00 | 2,912,443 | No | 4 | C | Indirect | by Beacon Bioventures Fund II Limited Partnership |
Common Stock | Acquisiton | 2014-01-30 | 172,797 | $0.00 | 3,085,240 | No | 4 | C | Indirect | by Beacon Bioventures Fund II Limited Partnership |
Common Stock | Acquisiton | 2014-01-31 | 175,000 | $21.00 | 3,260,240 | No | 4 | P | Indirect | by Beacon Bioventures Fund II Limited Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | by Beacon Bioventures Fund II Limited Partnership |
No | 4 | C | Indirect | by Beacon Bioventures Fund II Limited Partnership |
No | 4 | P | Indirect | by Beacon Bioventures Fund II Limited Partnership |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-01-30 | 9,129,063 | $0.00 | 2,912,443 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-01-30 | 541,634 | $0.00 | 172,797 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- On January 30, 2014, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into Common Stock on a 3.1345-for-1 basis.